Literature DB >> 16023947

Pre-operative imaging of rectal cancer and its impact on surgical performance and treatment outcome.

R G H Beets-Tan1, T Lettinga, G L Beets.   

Abstract

AIM: To discuss the ability of pre-operative MRI to have a beneficial effect on surgical performance and treatment outcome in patients with rectal cancer.
METHODS: A description on how MRI can be used as a tool so select patients for differentiated neoadjuvant treatment, how it can be used as an anatomical road map for the resection of locally advanced cases, and how it can serve as a tool for quality assurance of both the surgical procedure and overall patient management. As an illustration the proportion of microscopically complete resections of the period 1993-1997, when there was no routine pre-operative imaging, is compared to that of the period 1998-2002, when pre-operative MR imaging was standardized.
RESULTS: The proportion of R0 resections increased from 92.5 to 97% (p=0.08) and the proportion of resections with a lateral tumour free margin of >1mm increased from 84.4 to 92.1% (p=0.03). The incomplete resections in the first period were mainly due to inadequate surgical management of unsuspected advanced or bulky tumours, whereas in the second period insufficient consideration was given to extensive neoadjuvant treatment when the tumour was close to or invading the mesorectal fascia on MR.
CONCLUSIONS: There are good indications that in our setting pre-operative MR imaging, along with other improvements in rectal cancer management, had a beneficial effect on patient outcome. Audit and discussion of the incomplete resections can lead to an improved operative and perioperative management.

Entities:  

Mesh:

Year:  2005        PMID: 16023947     DOI: 10.1016/j.ejso.2005.02.015

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  5 in total

1.  Prediction of tumor stage and lymph node involvement with dynamic contrast-enhanced MRI after chemoradiotherapy for locally advanced rectal cancer.

Authors:  Wijnand J Alberda; Helene P N Dassen; Roy S Dwarkasing; François E J A Willemssen; Anne E M van der Pool; Johannes H W de Wilt; Jacobus W A Burger; Cornelis Verhoef
Journal:  Int J Colorectal Dis       Date:  2012-09-22       Impact factor: 2.571

Review 2.  Intersphincteric resection for very low rectal cancer: a systematic review.

Authors:  Yoshito Akagi; Tetsushi Kinugasa; Kazuo Shirouzu
Journal:  Surg Today       Date:  2012-11-09       Impact factor: 2.549

3.  Total mesorectal excision for rectal cancer in an unselected population: quality assessment in a low volume center.

Authors:  Floris T J Ferenschild; Imro Dawson; Johannes H W de Wilt; Eelco J R de Graaf; Richard P R Groenendijk; Geert W M Tetteroo
Journal:  Int J Colorectal Dis       Date:  2009-06-02       Impact factor: 2.571

4.  Preoperative radiotherapy and curative surgery for the management of localised rectal carcinoma.

Authors:  Iosief Abraha; Cynthia Aristei; Isabella Palumbo; Marco Lupattelli; Stefano Trastulli; Roberto Cirocchi; Rita De Florio; Vincenzo Valentini
Journal:  Cochrane Database Syst Rev       Date:  2018-10-03

Review 5.  Intersphincteric resection for very low rectal cancer: A review of the updated literature.

Authors:  Kazuo Shirouzu; Naotaka Murakami; Yoshito Akagi
Journal:  Ann Gastroenterol Surg       Date:  2017-04-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.